Literature DB >> 26212778

Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.

Brandon T Larsen1,2, Oana M Mereuta1,3, Surendra Dasari4, Ahmed U Fayyaz1, Jason D Theis1, Julie A Vrana1, Martha Grogan5, Ahmet Dogan1,3, Angela Dispenzieri6, William D Edwards1,5, Paul J Kurtin1, Joseph J Maleszewski1,5.   

Abstract

AIMS: Prognostication and treatment selection for cardiac amyloidosis requires accurate amyloid typing. The aim of this study was to investigate the utility of histomorphology for predicting type. METHODS AND
RESULTS: Autopsy cases with cardiac amyloidosis (1998-2010) were typed by the use of mass spectrometry-based proteomics. Deposition patterns were correlated with amyloid type. Among 108 decedents (mean age 75 years; 69% men), 107 had a single type, including transthyretin (ATTR) (60 cases), amyloid light chain (AL) (32 λ; 12 κ), amyloid A (AA) (two), and apolipoprotein AIV (AApoAIV) (one). Interstitial deposition was more extensive in AL amyloidosis cases than in ATTR cases [odds ratio (OR) 6.8, P = 0.0004]. Histomorphological patterns of interstitial deposition were mixed in 61% of AL amyloidosis cases and in 61% of ATTR cases, but diffuse pericellular deposits favoured AL amyloidosis (OR 10.7, P = 0.0001), nodular deposits favoured ATTR (OR 3.1, P = 0.0229), and discrete pericellular deposits tended to partially favour ATTR (OR 1.7, P = 0.1970). Arterial and venous deposits each favoured AL amyloidosis (OR ranging from 9.3 to 192.0, P-value ranging from 0.0022 to <0.0001), and were severe in AL amyloidosis. Endocardial deposits favoured AL amyloidosis (OR 46.3, P < 0.0001) and were also more severe in AL amyloidosis.
CONCLUSIONS: The extent and distribution of cardiac amyloidosis strongly correlate with amyloid type, suggesting fundamental differences in the pathobiology of deposition. The tendency for mixed patterns to occur limits the practicality and accuracy of using histopathology for amyloid typing.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  AL amyloid; ATTR amyloid; amyloid; amyloid typing; cardiac amyloidosis; histomorphology; mass spectrometry; proteomics

Mesh:

Substances:

Year:  2015        PMID: 26212778     DOI: 10.1111/his.12793

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Microvascular dysfunction in infiltrative cardiomyopathies.

Authors:  Ornella Rimoldi; Francesco Maranta
Journal:  J Nucl Cardiol       Date:  2017-07-11       Impact factor: 5.952

2.  Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic; Astrid Weins
Journal:  Virchows Arch       Date:  2020-05-09       Impact factor: 4.064

Review 3.  Cardiac Amyloid - An Update.

Authors:  Jason N Dungu
Journal:  Eur Cardiol       Date:  2015-12

Review 4.  Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.

Authors:  Jan M Griffin; Hannah Rosenblum; Mathew S Maurer
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

5.  Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies.

Authors:  P Patrizia Mangione; Giuseppe Mazza; Janet A Gilbertson; Nigel B Rendell; Diana Canetti; Sofia Giorgetti; Luca Frenguelli; Marco Curti; Tamer Rezk; Sara Raimondi; Mark B Pepys; Philip N Hawkins; Julian D Gillmore; Graham W Taylor; Massimo Pinzani; Vittorio Bellotti
Journal:  J Proteomics       Date:  2017-06-21       Impact factor: 4.044

Review 6.  Molecular Mechanisms of Cardiac Amyloidosis.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

7.  Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis.

Authors:  Emanuel Zampiccoli; Jens Barthelmes; Leonie Kreysing; Matthias P Nägele; Delia Nebunu; Thomas Haider; Arnold von Eckardstein; Bernhard Gerber; Rahel Schwotzer; Frank Ruschitzka; Isabella Sudano; Andreas J Flammer
Journal:  ESC Heart Fail       Date:  2022-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.